BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
An Observational Study to Learn More About How Menopause Affects Women's Sleep and How They Are Being Treated for Sleep Problems
Recruiting
- Conditions
- First Posted Date
- 2024-12-11
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1000
- Registration Number
- NCT06728332
- Locations
- 🇺🇸
Bayer, Whippany, New Jersey, United States
An Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in Japan
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-20
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Bayer
- Target Recruit Count
- 7000
- Registration Number
- NCT06697353
- Locations
- 🇯🇵
Many Locations, Multiple Locations, Japan
A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-28
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Bayer
- Target Recruit Count
- 100
- Registration Number
- NCT06661122
- Locations
- 🇯🇵
Many locations, Multiple Locations, Japan
A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-26
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Bayer
- Target Recruit Count
- 104
- Registration Number
- NCT06659341
- Locations
- 🇦🇺
Macquarie University Hospital, Macquarie Park, New South Wales, Australia
🇦🇺Peninsula and Southeast Oncology, Frankston, Victoria, Australia
🇩🇰Rigshospitalet - Kræftbehandling, Copenhagen OE, Denmark
A Study to Learn if There is a Difference in the Blood Levels of Acetylsalicylic Acid When Taken as Different Chewable Tablets on an Empty Stomach by Healthy Participants
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-23
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 38
- Registration Number
- NCT06655194
- Locations
- 🇲🇽
IPharma, S.A. de C.V., Monterrey, Nuevo Leon, Mexico
An Observational Study to Learn More About How Safe Vericiguat is and How Well it Works in Indian People With Chronic Heart Failure With Reduced Ejection Fraction and Worsening Chronic Heart Failure Under Real World Conditions
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-09
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1200
- Registration Number
- NCT06632483
- Locations
- 🇮🇳
Many locations, Multiple Locations, India
A Study to Learn How Safe BAY3018250 Is, How It Moves Into, Through and Out of the Body, and How It Affects the Body in Healthy Chinese Participants
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Bayer
- Target Recruit Count
- 24
- Registration Number
- NCT06619483
- Locations
- 🇨🇳
The First Affiliated Hospital of Guangzhou University of TCM, Guangzhou, Guangdong, China
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Bayer
- Target Recruit Count
- 150000
- Registration Number
- NCT06608212
- Locations
- 🇺🇸
Bayer, Whippany, New Jersey, United States
A Study to Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 45
- Registration Number
- NCT06591598
- Locations
- 🇭🇺
Semmelweis Egyetem, Budapest, Hungary
🇭🇺Budapest Retina Associates, Budapest, Hungary
🇨🇿Fakultní nemocnice Královské Vinohrady - Urologická klinikay, Praha 10, Czechia
A Study to Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years
- First Posted Date
- 2024-08-20
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Bayer
- Target Recruit Count
- 39
- Registration Number
- NCT06562985
- Locations
- 🇺🇸
Collaborative Neuroscience Research, LLC, Los Alamitos, California, United States
© Copyright 2024. All Rights Reserved by MedPath